Specific CYP450 gene polymorphisms were associated with prognostic factors in BC (Table 3), such as tumor stage, hormone receptor status (estrogen and progesterone receptors), and human epidermal growth factor receptor 2 (HER2) status. This evidence concerns the gene ERBB2 and breast cancer.